Prati
Liliana Ostopovici-Halip
Liliana Ostopovici-Halip
The Institute of Chemistry, Timisoara
Potvrđena adresa e-pošte na acad-icht.tm.edu.ro
Naslov
Citirano
Citirano
Godina
WOMBAT: world of molecular bioactivity
M Olah, M Mracec, L Ostopovici, R Rad, A Bora, N Hadaruga, I Olah, ...
Chemoinformatics in drug discovery 1, 2004
1592004
WOMBAT: world of molecular bioactivity
M Olah, M Mracec, L Ostopovici, R Rad, A Bora, N Hadaruga, I Olah, ...
Chemoinformatics in drug discovery 1, 2004
1592004
Modulation of bitter taste perception by a small molecule hTAS2R antagonist
JP Slack, A Brockhoff, C Batram, S Menzel, C Sonnabend, S Born, ...
Current Biology 20 (12), 1104-1109, 2010
1532010
A crowdsourcing evaluation of the NIH chemical probes
TI Oprea, CG Bologa, S Boyer, RF Curpan, RC Glen, AL Hopkins, ...
Nature chemical biology 5 (7), 441-447, 2009
1232009
Lead-like, drug-like or “Pub-like”: how different are they?
TI Oprea, TK Allu, DC Fara, RF Rad, L Ostopovici, CG Bologa
Journal of Computer-Aided Molecular Design 21 (1), 113-119, 2007
1172007
WOMBAT and WOMBAT‐PK: bioactivity databases for lead and drug discovery
M Olah, R Rad, L Ostopovici, A Bora, N Hadaruga, D Hadaruga, ...
Chemical biology: from small molecules to systems biology and drug design 1 …, 2007
1102007
DrugCentral 2021 supports drug discovery and repositioning
S Avram, CG Bologa, J Holmes, G Bocci, TB Wilson, DT Nguyen, ...
Nucleic acids research 49 (D1), D1160-D1169, 2021
692021
Real-time analysis of conformation-sensitive antibody binding provides new insights into integrin conformational regulation
A Chigaev, A Waller, O Amit, L Halip, CG Bologa, LA Sklar
Journal of Biological Chemistry 284 (21), 14337-14346, 2009
582009
Structural determinants of the alpha2 adrenoceptor subtype selectivity
L Ostopovici-Halip, R Curpăn, M Mracec, CG Bologa
Journal of Molecular Graphics and Modelling 29 (8), 1030-1038, 2011
252011
Conformational mAb as a tool for integrin ligand discovery
BH Njus, A Chigaev, A Waller, D Wlodek, L Ostopovici-Halip, O Ursu, ...
Assay and drug development technologies 7 (5), 507-515, 2009
252009
FRET detection of lymphocyte function–associated antigen-1 conformational extension
A Chigaev, Y Smagley, MK Haynes, O Ursu, CG Bologa, L Halip, T Oprea, ...
Molecular biology of the cell 26 (1), 43-54, 2015
192015
Three small molecule pan activator families of Ras-related GTPases
Z Surviladze, O Ursu, F Miscioscia, R Curpan, L Halip, C Bologa, T Oprea, ...
Probe Reports from the NIH Molecular Libraries Program [Internet], 2010
162010
On the propagation of errors in the QSAR literature
TI Oprea, M Olah, L Ostopovici, R Rad, M Mracec
EuroQSAR, 314-315, 2002
152002
Synthesis, structure and toxicity evaluation of ethanolamine nitro/chloronitrobenzoates: a combined experimental and theoretical study
M Crisan, L Halip, P Bourosh, SA Chicu, Y Chumakov
Chemistry Central Journal 11 (1), 1-10, 2017
142017
Modeling kinase inhibition using highly confident data sets
S Avram, A Bora, L Halip, R Curpăn
Journal of Chemical Information and Modeling 58 (5), 957-967, 2018
122018
A QSAR study using MTD method and Dragon descriptors for a series of selective ligands of α2C adrenoceptor
A Borota, M Mracec, A Gruia, R Rad-Curpăn, L Ostopovici-Halip, ...
European journal of medicinal chemistry 46 (3), 877-884, 2011
112011
Novel drug targets in 2019.
S Avram, L Halip, R Curpan, TI Oprea
Nature Reviews Drug Discovery 19 (5), 300-301, 2020
102020
Exploring the binding site of the human muscarinic M3 Receptor: homology modeling and docking study
L Ostopovici, M Mracec, M Mracec, A Borota
International Journal of Quantum Chemistry 107 (8), 1794-1802, 2007
102007
Off-patent drug repositioning
S Avram, R Curpan, L Halip, A Bora, TI Oprea
Journal of Chemical Information and Modeling 60 (12), 5746-5753, 2020
72020
3D Homology model of the α2b-adrenergic receptor subtype
L Ostopovici-Halip, A Borota, A Gruia, M Mracec, R Rad-Curpan, ...
Rev. Roum. Chim 55 (5), 343-348, 2010
72010
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20